SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Brasileiro58 who wrote (34206)5/3/2005 10:35:18 AM
From: rrufff  Read Replies (1) of 120415
 
GNBT - it's a typical bash/hype play. They are trying to get the price over a buck to keep the NAZ listing and hired an outfit that specializes in maximizing value and which claims a very high success rate. The MM's, perhaps naked shorts, perhaps hedge funds, know this and want to keep it under a buck. You already have 2.5 million shares today.

You see this often. It's NOT a coincidence that it went up to 1.27 and then has settled down to a buck.

I figure the company will milk this news today, which is the first news they have had in a long time, with respect to CURRENT POTENTIAL. By that I mean, they have what appears to be great potential in the cancer area but that would be years away, unless they are taken over, for a payoff.

This particular news, re Oralyn for diabetes, should lead to a revenue stream and the potential numbers are huge even if it's just South America for now.

So, I'm playing it 2 ways. Buy on dips for a short term gain probably no higher than about 1.35, given today's action. Longer term, I suspect we should see close to $2 or even more.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext